Embecta Corp. Common Stock earnings per share and revenue
On Nov 25, 2025, EMBC reported earnings of 0.50 USD per share (EPS) for Q4 25, missing the estimate of 0.54 USD, resulting in a -8.66% surprise. Revenue reached 264.00 million, compared to an expected 271.00 million, with a -2.58% difference. The market reacted with a -7.24% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analysts forecast an EPS of 0.68 USD, with revenue projected to reach 263.20 million USD, implying an increase of 36.00% EPS, and decrease of -0.30% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
FAQ
What were Embecta Corp. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Embecta Corp. Common Stock reported EPS of $0.50, missing estimates by -8.66%, and revenue of $264.00M, -2.58% below expectations.
How did the market react to Embecta Corp. Common Stock's Q4 2025 earnings?
The stock price moved down -7.24%, changed from $14.64 before the earnings release to $13.58 the day after.
When is Embecta Corp. Common Stock expected to report next?
The next earning report is scheduled for Feb 05, 2026.
What are the forecasts for Embecta Corp. Common Stock's next earnings report?
Based on 5
analysts, Embecta Corp. Common Stock is expected to report EPS of $0.68 and revenue of $263.20M for Q1 2026.